Century Therapeutics Inc (IPSC) — Capital Reinvestment Ratio
Century Therapeutics Inc (IPSC) has a Capital Reinvestment Ratio of 0.05x as of March 2022, meaning it reinvests 0% of its operating cash flow ($86.75 Million) in capital expenditures ($4.07 Million). Check Century Therapeutics Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Century Therapeutics Inc Capital Reinvestment Ratio (2015–2022)
This chart tracks Century Therapeutics Inc's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see IPSC operating cash flow.
Annual Capital Reinvestment Ratio for Century Therapeutics Inc (2015–2022)
Year-by-year Capital Reinvestment Ratio for Century Therapeutics Inc from 2015 to 2022. See free cash flow generation of Century Therapeutics Inc to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 2.18x | $14.05 Million | $30.60 Million | ▲ +672.7% |
| 2015 | 0.28x | $104.30 Million | $29.39 Million | — |